| Product Code: ETC6657454 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Gene Therapy Products Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Gene Therapy Products Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Gene Therapy Products Market - Industry Life Cycle |
3.4 Canada Gene Therapy Products Market - Porter's Five Forces |
3.5 Canada Gene Therapy Products Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Canada Gene Therapy Products Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Canada Gene Therapy Products Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Gene Therapy Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in the field of gene therapy |
4.2.2 Rising prevalence of genetic disorders and chronic diseases in Canada |
4.2.3 Favorable regulatory environment supporting the development and commercialization of gene therapy products |
4.3 Market Restraints |
4.3.1 High cost associated with gene therapy products |
4.3.2 Limited awareness and acceptance of gene therapy among patients and healthcare providers |
4.3.3 Challenges related to manufacturing and scalability of gene therapy products |
5 Canada Gene Therapy Products Market Trends |
6 Canada Gene Therapy Products Market, By Types |
6.1 Canada Gene Therapy Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Canada Gene Therapy Products Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Canada Gene Therapy Products Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.1.4 Canada Gene Therapy Products Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.1.5 Canada Gene Therapy Products Market Revenues & Volume, By Luxturna, 2021- 2031F |
6.1.6 Canada Gene Therapy Products Market Revenues & Volume, By Strimvelis, 2021- 2031F |
6.1.7 Canada Gene Therapy Products Market Revenues & Volume, By Gendicine, 2021- 2031F |
6.2 Canada Gene Therapy Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Canada Gene Therapy Products Market Revenues & Volume, By Oncological Disorders, 2021- 2031F |
6.2.3 Canada Gene Therapy Products Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.2.4 Canada Gene Therapy Products Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.5 Canada Gene Therapy Products Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.6 Canada Gene Therapy Products Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.7 Canada Gene Therapy Products Market Revenues & Volume, By Other Diseases, 2021- 2031F |
6.3 Canada Gene Therapy Products Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Canada Gene Therapy Products Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Canada Gene Therapy Products Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.4 Canada Gene Therapy Products Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.5 Canada Gene Therapy Products Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Gene Therapy Products Market Import-Export Trade Statistics |
7.1 Canada Gene Therapy Products Market Export to Major Countries |
7.2 Canada Gene Therapy Products Market Imports from Major Countries |
8 Canada Gene Therapy Products Market Key Performance Indicators |
8.1 Number of clinical trials for gene therapy products in Canada |
8.2 Adoption rate of gene therapy products by healthcare providers |
8.3 Rate of reimbursement for gene therapy treatments in Canada |
9 Canada Gene Therapy Products Market - Opportunity Assessment |
9.1 Canada Gene Therapy Products Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Canada Gene Therapy Products Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Canada Gene Therapy Products Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Gene Therapy Products Market - Competitive Landscape |
10.1 Canada Gene Therapy Products Market Revenue Share, By Companies, 2024 |
10.2 Canada Gene Therapy Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here